Related Experiment Videos
T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis)
A J Barnett1, B D Tait, M A Barnett
1Tissue Typing Laboratory, Royal Melbourne Hospital, Australia.
Clinical and Experimental Immunology
|April 1, 1989
Summary
Scleroderma patients show reduced CD8 (suppressor-cytotoxic) T cells and distinct HLA profiles, particularly DRw8 in CD8-deficient individuals. These immune variations suggest scleroderma
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Scleroderma is a complex autoimmune disease affecting connective tissues.
- T lymphocyte subsets play a crucial role in immune regulation.
- Human Leukocyte Antigen (HLA) profiles are associated with autoimmune disease susceptibility.
Purpose of the Study:
- To investigate T lymphocyte subset alterations in scleroderma patients.
- To correlate these T cell changes with specific HLA phenotypes.
- To explore the heterogeneity of scleroderma based on immunological and genetic markers.
Main Methods:
- Analysis of T lymphocyte subsets (CD4, CD8) in 50 scleroderma patients.
- HLA phenotyping (including DRw8, B18, DR4, DRw53, DR5) in 46 patients.
- Subgrouping patients based on CD8 cell counts and clinical disease extent.
Main Results:
- 22 patients had depressed total lymphocyte counts; CD4 (helper) cells were normal.
- 27 patients had reduced CD8 (suppressor-cytotoxic) cells, with 30 classified as CD8-deficient.
- DRw8 was significantly increased in CD8-deficient patients.
- B18 associated with limited sclerosis; DR4, DRw53 decreased and DR5 increased with extensive sclerosis.
Conclusions:
- Scleroderma exhibits heterogeneity reflected in T cell subset profiles and HLA associations.
- CD8 deficiency is linked to specific HLA types (DRw8), suggesting distinct disease pathways.
- Clinical presentation and immune markers correlate, highlighting the need for personalized approaches in scleroderma management.